<SEC-DOCUMENT>0001683168-17-001069-index.html : 20170502 <SEC-HEADER>0001683168-17-001069.hdr.sgml : 20170502 <ACCEPTANCE-DATETIME>20170502080733 ACCESSION NUMBER: 0001683168-17-001069 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20170501 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20170502 DATE AS OF CHANGE: 20170502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PharmaCyte Biotech, Inc. CENTRAL INDEX KEY: 0001157075 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 621772151 STATE OF INCORPORATION: NV FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-68008 FILM NUMBER: 17802968 BUSINESS ADDRESS: STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600 CITY: LAGUNA HILLS STATE: CA ZIP: 92653 BUSINESS PHONE: (917) 595.2850 MAIL ADDRESS: STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600 CITY: LAGUNA HILLS STATE: CA ZIP: 92653 FORMER COMPANY: FORMER CONFORMED NAME: NUVILEX, INC. DATE OF NAME CHANGE: 20090324 FORMER COMPANY: FORMER CONFORMED NAME: EFOODSAFETY COM INC DATE OF NAME CHANGE: 20010808 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>pharmabio_8k-050117.htm <DESCRIPTION>CURRENT REPORT <TEXT> Document 1 - file: pharmabio_8k-050117.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>2 <FILENAME>pharmabio_8k-ex1001.htm <DESCRIPTION>LETTER AGREEMENT <TEXT> Document 2 - file: pharmabio_8k-ex1001.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>3 <FILENAME>pharmabio_8k-ex9901.htm <DESCRIPTION>PRESS RELEASE <TEXT> Document 3 - file: pharmabio_8k-ex9901.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>image_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: image_001.jpg
</DOCUMENT> </SEC-DOCUMENT>